Studies involving disease:Parkinsons disease
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST001281 | Transgenic Parkinson's Mice Following Immunotherapy | Mouse | University of Florida |
| ST001810 | Metabolomics-driven identification of biochemical mechanisms underlying the neuroprotective effects of pleiotrophin in a mouse model of Parkinson’s disease | Mouse | CEMBIO |
| ST001814 | Searching for prognostic biomarkers of Parkinson´s Disease development in the Spanish EPIC cohort through a multiplatform metabolomics approach | Human | Universidad CEU San Pablo |
| ST001957 | Untargeted Mass Spectrometry Metabolomic Profiles of iPSC-derived Dopaminergic Neurons from Clinically Discordant Brothers with Identical PRKN Deletions | Human | Vanderbilt University |
| ST002335 | Pathogenic Auxilin mutations affect lipids that are critical to Synaptojanin function | Fruit fly | VIB-KU Leuven |
| ST002389 | Alterations in SHH signal transduction introduce a state of hypometabolism in sporadic Parkinson's disease | Human | Helmholtz Centre for Environmental Research |
| ST003159 | Untargeted serum metabolomics in the Parkinson's Environment and Genes (PEG) Study | Human | University of California, Los Angeles |
| ST003438 | Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease | Fruit fly | Broad Institute of MIT and Harvard |
| ST003589 | Metabolomics of Drosophila melanogaster under manganese (Mn) exposure (head) | Fruit fly | Columbia University |
| ST003590 | Metabolomics of Drosophila melanogaster under manganese (Mn) exposure (body) | Fruit fly | Columbia University |
| ST004058 | Targeted Lipid and Metabolite Profiling in ATP13A2 knockout (KO) in HAP1 cells | Human | Denali Therapeutics |
| ST004059 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Mouse | Denali Therapeutics |
| ST004162 | Targeted Lipid Profiling of Mouse Brains with GBA1 E326K Loss-of-Function | Mouse | Denali Therapeutics |
| ST004163 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Human | Denali Therapeutics |
